Goodness Growth Holdings to Participate in Minnesota Cannabis Symposium for Healthcare Providers

Two-day event will feature medical cannabis experts, clinical researchers, CME courses, and a tour of cannabis cultivation facility

- Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a physician-led, science-focused cannabis company and IP developer, today announced that its Minnesota subsidiary, Vireo Health of Minnesota LLC, is participating in a two-day symposium for interested medical professionals to learn more about medical cannabis. The Spring into Cannabis Symposium will be one of the first medical cannabis-focused events to offer Continuing Medical Education ("CME") credits to healthcare practitioners.

Goodness Growth Holdings (CSE: GDNS; OTCQX: GDNSF) is the new parent company of Vireo Health and Green Goods. (PRNewsfoto/Goodness Growth Holdings)

The Spring into Cannabis Symposium will include an all-day educational conference with physicians, researchers, patient advocates, and policy experts from around the country presenting on key topics including cannabis as an alternative to opioids, medical cannabis in neurology and mental health, pediatric uses of medical cannabis, and more. Attendees will have the opportunity to earn up to six continuing medical education credits.

"We are thrilled to offer physicians and practitioners what they have requested for so long, evidence-based medical cannabis courses for continuing medical education," said Stephen Dahmer , M.D., Chief Medical Officer of Goodness Growth. "For over seven years, Goodness Growth and Vireo Health have been at the forefront of medical cannabis science, education and research. This CME event will showcase the very best of that research, evidence, practical knowledge, and patient stories. Physicians and providers are key to our nation overcoming the stigma around cannabis once and for all. We are proud to help fill this unfortunate gap in our medical education."

Sherry Yafai , MD, medical director at the Releaf institute, a national medical cannabis expert and Board-Certified Emergency Medicine Physician, will give the keynote discussion. The second day of the symposium will feature a guided VIP tour of the Company's cannabis cultivation facility in nearby Otsego, MN.

The symposium will also feature a presentation on the recent advancements to the Minnesota Medical Cannabis Program and an overview on how the program works. On March 1, 2022 , Minnesota allowed the sale of dry cannabis flower to registered patients for the first time.

"Cannabis has been used as a medicine for thousands of years for ailments ranging from chronic pain to mental health conditions. It is only recently that cannabis has been stigmatized, removed from the United States Pharmacopeia, and incorrectly categorized as a Schedule 1 substance," said Paloma Lehfeldt , M.D., Senior Director of Clinical Science at Goodness Growth. "With over 6 million users of cannabis in the United States , it is imperative that our healthcare providers are well-versed in both our endogenous cannabis system as well as cannabis plant medicine. The goal of this provider symposium is to help fill in the many knowledge gaps that medical professionals have with regards to medical cannabis."

Find more details and register for the Symposium at: https://visitgreengoods.com/register-now-to-spring-into-cannabis/

About Goodness Growth Holdings, Inc.

Goodness Growth Holdings, Inc., is a physician-led, science-focused holding company whose mission is to bring the power of plants to the world. The Company's operations consist primarily of its multi-state cannabis company subsidiary, Vireo Health, Inc., and its science and intellectual property incubator, Resurgent Biosciences, Inc. The Company manufactures proprietary, branded cannabis products in environmentally friendly facilities and state-of-the-art cultivation sites and distributes its products through its growing network of Green Goods® and other retail locations and third-party dispensaries. Its teams of more than 500 employees are focused on the development of differentiated products, driving scientific innovation of plant-based medicines, and developing meaningful intellectual property. Today, the Company is licensed to grow, process, and/or distribute cannabis in eight markets and operates 18 dispensaries across the United States . For more information about Goodness Growth Holdings, please visit www.goodnessgrowth.com .

Contact Information

Media Inquiries:
Albe Zakes
Vice President, Corporate Communications
albezakes@goodnessgrowth.com
(267) 221-4800

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/goodness-growth-holdings-to-participate-in-minnesota-cannabis-symposium-for-healthcare-providers-301502781.html

SOURCE Goodness Growth Holdings, Inc.

News Provided by PR Newswire via QuoteMedia

CNX:GDNS,GDNSF
The Conversation (0)

Trulieve to Open Medical Cannabis Dispensary in Tampa, Florida

New Hillsborough County location will host grand opening celebration Friday December 13

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Tampa, Florida .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Cannabis leaves, US flag.

Cannabis Round-Up: DEA Postpones Rescheduling Hearing, Key Players Share Quarterly Results

November was a busy month for the cannabis industry, with a slew of US-centric developments.

A hearing on cannabis rescheduling was postponed until 2025, although the incoming Trump administration has signaled its intent to follow through on the change despite opposition from some Republican lawmakers.

Meanwhile, several states voted on cannabis measures, and companies reported their latest quarterly results.

Keep reading...Show less
Cannabis plants and a stock chart.

US Cannabis Sales Hit Record in October, Market Set to Reach US$55 Billion by 2030

Cannabis sales in the US reached a record high in October, with retail transactions totaling approximately US$2.8 billion, according to data from LeafLink, a wholesale cannabis platform.

While sales saw a slight 2.1 percent dip compared to September, they were up 6.2 percent year-on-year. Total retail cannabis sales in 2024 are expected to hit US$32.6 billion, representing a 10.8 percent increase over the previous year.

LeafLink attributes much of this growth to new licenses in states such as New York, New Jersey and Ohio.

Keep reading...Show less
Australia flag and cannabis.

Australian Senate Rejects Greens' Bill to Legalise Cannabis

The Australian Greens announced on Wednesday, November 27, that the Legalising Cannabis Bill 2023 was defeated in a 13 to 24 vote, preventing the federal legalisation of cannabis.

“The Labor and Coalition parties joined together to try and hold Australia back in the 1950s by blocking this desperately needed reform,” said Greens Senator for New South Wales David Shoebridge.

Shoebridge said on X that the parties “teamed up” to vote against legalizing cannabis in the Senate, “yet another example of the major parties working together to refuse any sort of progress.”

All 11 Greens Senators voted in favour of the Bill, as did Independent Senators Lidia Thorpe and Tammy Tyrrell.

Keep reading...Show less
Cannabis and Australian money.

Victoria Amends Driving Rules for Medicinal Cannabis Users, Changes Effective in Mid-2025

Both houses of parliament in Victoria, Australia, have successfully passed the Roads and Road Safety Legislation Amendment Bill 2024, Cannabis Council Australia said in a recent newsletter.

The organisation sees this as a “promising development” in the area, calling it a “critical legislative milestone." The bill's passing will allow for judicial discretion when decisions about medicinal cannabis are made.

Magistrates will now have the ability to evaluate individual cases where drivers who hold valid medicinal cannabis prescriptions test positive for THC, but show no signs of impairment.

Keep reading...Show less

Trulieve to Open Medical Cannabis Dispensary in Jacksonville, Florida

New Duval County location will host grand opening celebration Friday, December 6 th

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., announced the opening of a new medical cannabis dispensary in Jacksonville, Florida on Saturday, November 23 .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×